Growth-inhibitory effect of combination chemotherapy for human pancreatic cancer cell lines.

Matsuno, S; Hisano, H; Kobari, M; Akaishi, S

Matsuno, S; Hisano, H; Kobari, M; Akaishi, S.

Affiliation

Matsuno S; First Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.

Cancer ; 66(11): 2369-74, 1990 Dec 01.

Article in En | MEDLINE | ID: mdl-2123126

Subject(s)

Antineoplastic Agents/therapeutic use; Carcinoma/drug therapy; Cell Division/drug effects; Pancreatic Neoplasms/drug therapy; Aclarubicin/administration & dosage; Animals; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cisplatin/administration & dosage; Dose-Response Relationship, Drug; Doxorubicin/administration & dosage; Drug Synergism; Fluorouracil/administration & dosage; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins/administration & dosage; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma / Cell Division / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Cancer Year: 1990 Document type: Article Affiliation country: Japan Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links